|
|
|
ix | |
| Foreword |
|
xi | |
|
|
|
|
|
|
|
|
|
|
14 | (8) |
|
2 Principles of Establishing and Operating a Gnotobiotic Facility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22 | (1) |
|
|
|
22 | (5) |
|
|
|
22 | (1) |
|
|
|
22 | (3) |
|
|
|
25 | (1) |
|
|
|
25 | (1) |
|
2.5 Microbiology Laboratory |
|
|
25 | (1) |
|
2.6 Facility Productivity and Experimental Utilization |
|
|
25 | (1) |
|
2.7 Facility Operation and Compliance |
|
|
26 | (1) |
|
|
|
27 | (5) |
|
3.1 Isolator Types and Construction |
|
|
27 | (5) |
|
3.2 Individual Positive Pressure Cage Systems |
|
|
32 | (1) |
|
|
|
32 | (6) |
|
|
|
33 | (1) |
|
|
|
34 | (1) |
|
|
|
34 | (3) |
|
4.4 Gas and Vapor Chemical |
|
|
37 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (14) |
|
5.1 Standard Operating Procedures |
|
|
38 | (1) |
|
|
|
38 | (2) |
|
5.3 Sterilization and Entry of Supplies |
|
|
40 | (5) |
|
5.4 Introduction and Transfer of Animals |
|
|
45 | (1) |
|
|
|
45 | (1) |
|
5.6 Monitoring for Contamination |
|
|
46 | (4) |
|
5.7 Derivation of Germfree Mice |
|
|
50 | (1) |
|
5.8 Establishing Defined Microbiota |
|
|
51 | (1) |
|
|
|
52 | (14) |
|
|
|
52 | (2) |
|
|
|
54 | (1) |
|
|
|
54 | (1) |
|
|
|
55 | (1) |
|
|
|
56 | (2) |
|
|
|
58 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
66 | (1) |
|
2 Background and Acknowledgments |
|
|
67 | (1) |
|
2.1 University of Texas Southwestern Medical Center (UT Southwestern) |
|
|
67 | (1) |
|
2.2 University of Michigan (Michigan) |
|
|
67 | (1) |
|
2.3 University of Alabama at Birmingham (UAB) |
|
|
67 | (1) |
|
2.4 Baylor College of Medicine (BCM) |
|
|
68 | (1) |
|
|
|
68 | (3) |
|
|
|
68 | (1) |
|
|
|
68 | (1) |
|
|
|
69 | (2) |
|
4 Sterilization and Sterilization Monitoring |
|
|
71 | (15) |
|
|
|
74 | (1) |
|
|
|
75 | (8) |
|
|
|
83 | (3) |
|
|
|
86 | (50) |
|
|
|
86 | (28) |
|
|
|
114 | (11) |
|
|
|
125 | (11) |
|
|
|
136 | (5) |
|
|
|
136 | (2) |
|
|
|
138 | (3) |
|
|
|
141 | (1) |
|
7 Transferring Supplies Into Isolators |
|
|
141 | (42) |
|
|
|
142 | (19) |
|
|
|
161 | (12) |
|
|
|
173 | (10) |
|
|
|
183 | (107) |
|
|
|
184 | (39) |
|
|
|
223 | (1) |
|
|
|
224 | (44) |
|
|
|
268 | (22) |
|
|
|
290 | (8) |
|
|
|
293 | (3) |
|
|
|
296 | (2) |
|
10 Microbiological Monitoring |
|
|
298 | (12) |
|
|
|
298 | (6) |
|
|
|
304 | (1) |
|
|
|
305 | (5) |
|
11 Records and Maintenance |
|
|
310 | (2) |
|
|
|
311 | (1) |
|
|
|
312 | (1) |
|
12 Derivation of Germfree Mice |
|
|
312 | (5) |
|
|
|
313 | (1) |
|
|
|
313 | (4) |
|
13 Establishing Microbiota in Germfree Mice |
|
|
317 | (1) |
|
|
|
317 | (1) |
|
14 Alternatives to Isolators |
|
|
318 | (2) |
|
|
|
319 | (1) |
|
15 Shipping and Receiving Mice |
|
|
320 | (3) |
|
|
|
321 | (2) |
|
16 Materials Lists and Fabrication Diagrams |
|
|
323 | (12) |
|
|
|
323 | (10) |
|
|
|
333 | (2) |
|
4 Developing a Business Plan for Your Gnotobiotics Program |
|
|
|
|
|
|
|
|
|
335 | (1) |
|
2 Operational Management Considerations in Establishing a Gnotobiotics Program |
|
|
335 | (2) |
|
3 Developing a Business Model |
|
|
337 | (5) |
|
3.1 Identifying the Users and Volume of Work |
|
|
337 | (2) |
|
3.2 Identifying Space and Equipment Requirements |
|
|
339 | (2) |
|
3.3 Labor---What Products and Services Will Be provided and Who Will Provide Them |
|
|
341 | (1) |
|
|
|
342 | (4) |
|
|
|
342 | (2) |
|
|
|
344 | (1) |
|
|
|
345 | (1) |
|
4.4 Quality Control Costs |
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
347 | (1) |
|
|
|
347 | (1) |
|
|
|
347 | (2) |
|
|
|
348 | (1) |
|
5 Gnotobiotic Pigs: From Establishing Facility to Modeling Human Infectious Diseases |
|
|
|
|
|
|
|
|
|
1 History of Gnotobiotic Pigs |
|
|
349 | (1) |
|
2 Establishing and Operating a Gnotobiotic Pig Facility |
|
|
350 | (10) |
|
|
|
350 | (1) |
|
2.2 Specialized Equipment |
|
|
351 | (2) |
|
|
|
353 | (1) |
|
|
|
354 | (1) |
|
2.5 Preparation of Isolators |
|
|
354 | (1) |
|
|
|
355 | (3) |
|
|
|
358 | (1) |
|
2.8 Spraying Materials Prior to Entry Into an Isolator |
|
|
359 | (1) |
|
2.9 Sample Collection and Administration of Inocula |
|
|
359 | (1) |
|
2.10 Cleaning a Dirty Isolator |
|
|
360 | (1) |
|
3 Gnotobiotic Pig Models for Studies of Infectious Diseases |
|
|
360 | (9) |
|
3.1 Gnotobiotic Pig Models for Human Enteric Viruses |
|
|
360 | (2) |
|
3.2 Gnotobiotic Pig Models for Bacterial and Fungal Infections |
|
|
362 | (1) |
|
3.3 Studies of Probiotics and Prebiotics Using Gnotobiotic Pigs |
|
|
362 | (1) |
|
3.4 Gnotobiotic Pigs Colonized With Human Gut Microbiota |
|
|
363 | (1) |
|
|
|
363 | (1) |
|
|
|
364 | (5) |
|
6 Gnotobiotic Fish as Models to Study Host--Microbe Interactions |
|
|
|
|
|
|
|
|
|
369 | (1) |
|
2 Brief Review of Fish Gnotobiology |
|
|
370 | (1) |
|
3 Protocol for Derivation and Husbandry of Gnotobiotic Fish |
|
|
371 | (1) |
|
|
|
371 | (1) |
|
5 Considerations for Disinfection of Eggs |
|
|
371 | (3) |
|
5.1 Polyvinylpyrrolidone--lodine |
|
|
372 | (1) |
|
5.2 Sodium Hypochlorite Solution |
|
|
373 | (1) |
|
|
|
373 | (1) |
|
|
|
373 | (1) |
|
5.5 Fish Husbandry in Water Containing Antimicrobial Agents |
|
|
373 | (1) |
|
6 Confirmation of Sterility |
|
|
374 | (1) |
|
6.1 Microscopic Visualization of Flask |
|
|
374 | (1) |
|
6.2 Culture-Based Detection |
|
|
374 | (1) |
|
6.3 PCR Amplification of the Bacteria-Specific 16S Ribosomal RNA Gene |
|
|
374 | (1) |
|
6.4 In Situ Hybridization |
|
|
374 | (1) |
|
|
|
375 | (1) |
|
|
|
375 | (2) |
|
7.1 Tissue Culture Flasks |
|
|
375 | (1) |
|
|
|
376 | (1) |
|
7.3 Beakers/Tanks in Gnotobiotic Bubble |
|
|
376 | (1) |
|
8 Food Considerations for Long-Term Experiments |
|
|
377 | (1) |
|
|
|
377 | (1) |
|
|
|
377 | (1) |
|
|
|
377 | (1) |
|
|
|
377 | (1) |
|
|
|
378 | (1) |
|
|
|
378 | (1) |
|
|
|
378 | (1) |
|
9 Other Considerations for Gnotobiotic Fish Husbandry |
|
|
378 | (1) |
|
10 Derivation of Germfree Stickleback Embryos |
|
|
379 | (6) |
|
|
|
380 | (1) |
|
|
|
380 | (5) |
|
7 Use of Gnotobiotic Mice in the Study of Metabolic Syndrome |
|
|
|
|
|
|
|
|
|
385 | (4) |
|
1.1 To What Extent Is a Microbiota Required for Metabolic Syndrome? |
|
|
386 | (1) |
|
1.2 Is an Altered Microbiota Sufficient to Drive Metabolic Syndrome? |
|
|
387 | (2) |
|
2 Conclusion and Future Directions |
|
|
389 | (2) |
|
|
|
389 | (1) |
|
|
|
389 | (2) |
|
8 Gnotobiotics and Inflammatory Bowel Disease |
|
|
|
|
|
|
|
391 | (3) |
|
2 Cytokines and Cytokine Signaling |
|
|
394 | (2) |
|
|
|
394 | (1) |
|
|
|
395 | (1) |
|
|
|
396 | (1) |
|
|
|
396 | (1) |
|
|
|
396 | (1) |
|
3 T-Cell Receptors and MHC |
|
|
396 | (1) |
|
3.1 T-Cell Receptor and MHC II Deficient Mice |
|
|
396 | (1) |
|
3.2 HLA B27 β2m Transgenic Rats |
|
|
397 | (1) |
|
|
|
397 | (2) |
|
4.1 Core 1-Derived O-Glycan Deficiency |
|
|
397 | (1) |
|
4.2 Fas-Associated via Death Domain Protein |
|
|
397 | (1) |
|
4.3 Glutathione Peroxidase Deficiency |
|
|
397 | (1) |
|
|
|
397 | (1) |
|
4.5 PI3 Kinase p110δ Deficiency |
|
|
398 | (1) |
|
4.6 Telomerase Deficiency |
|
|
398 | (1) |
|
|
|
398 | (1) |
|
|
|
398 | (1) |
|
|
|
399 | (2) |
|
|
|
401 | (1) |
|
|
|
401 | (1) |
|
|
|
401 | (1) |
|
|
|
401 | (1) |
| References |
|
401 | (10) |
| Index |
|
411 | |